UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

23 Mar 2005

UCB Group confirms its previously announced 2004 results and provides IFRS reconciliation and product update

Read More
1 Mar 2005

UCB: Closing Of The Sale Of Its Surface Specialties Division

Read More
17 Feb 2005

FDA grants priority review to levetiracetam for use in childhood epilepsy

Read More
7 Feb 2005

UCB Group preliminary full-year 2004 results

Read More
25 Jan 2005

UCB Pharma enters into agreement to collaborate on two Biotherapeutic Inflammation Programs with Millennium

Read More
19 Jan 2005

UCB Confirms Annual Zyrtec Sales In The US - Xyzal Sells More Than Zyrtec In Europe

Read More

Stay up-to-date on the latest news and information from UCB